Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1953 4
1956 2
1957 1
1964 2
1965 2
1966 1
1968 1
1969 3
1970 1
1971 1
1972 2
1976 1
1978 2
1980 1
1981 1
1982 5
1983 3
1984 3
1985 4
1986 1
1987 6
1988 7
1989 5
1990 5
1991 11
1992 14
1993 22
1994 23
1995 20
1996 17
1997 21
1998 19
1999 31
2000 27
2001 31
2002 63
2003 55
2004 87
2005 107
2006 109
2007 125
2008 147
2009 169
2010 176
2011 236
2012 255
2013 304
2014 344
2015 404
2016 442
2017 495
2018 539
2019 591
2020 651
2021 753
2022 920
2023 923
2024 277

Text availability

Article attribute

Article type

Publication date

Search Results

7,588 results

Results by year

Filters applied: . Clear all
Page 1
The landscape of cancer research and cancer care in China.
Lu Z, Chen Y, Liu D, Jiao X, Liu C, Wang Y, Zhang Z, Jia K, Gong J, Yang Z, Shen L. Lu Z, et al. Among authors: gong j. Nat Med. 2023 Dec;29(12):3022-3032. doi: 10.1038/s41591-023-02655-3. Epub 2023 Dec 12. Nat Med. 2023. PMID: 38087112 Review.
Safety and antitumour activity of cadonilimab, an anti-PD-1/CTLA-4 bispecific antibody, for patients with advanced solid tumours (COMPASSION-03): a multicentre, open-label, phase 1b/2 trial.
Gao X, Xu N, Li Z, Shen L, Ji K, Zheng Z, Liu D, Lou H, Bai L, Liu T, Li Y, Li Y, Fan Q, Feng M, Zhong H, Huang Y, Lou G, Wang J, Lin X, Chen Y, An R, Li C, Zhou Q, Huang X, Guo Z, Wang S, Li G, Fei J, Zhu L, Zhu H, Li X, Li F, Liao S, Min Q, Tang L, Shan F, Gong J, Gao Y, Zhou J, Lu Z, Li X, Li J, Ren H, Liu X, Yang H, Li W, Song W, Wang ZM, Li B, Xia M, Wu X, Ji J. Gao X, et al. Among authors: gong j. Lancet Oncol. 2023 Oct;24(10):1134-1146. doi: 10.1016/S1470-2045(23)00411-4. Lancet Oncol. 2023. PMID: 37797632 Clinical Trial.
Recent advances in the management of hepatocellular carcinoma.
Sankar K, Gong J, Osipov A, Miles SA, Kosari K, Nissen NN, Hendifar AE, Koltsova EK, Yang JD. Sankar K, et al. Among authors: gong j. Clin Mol Hepatol. 2024 Jan;30(1):1-15. doi: 10.3350/cmh.2023.0125. Epub 2023 Jul 21. Clin Mol Hepatol. 2024. PMID: 37482076 Free PMC article. Review.
Immunotherapy and Transarterial Radioembolization Combination Treatment for Advanced Hepatocellular Carcinoma.
Yeo YH, Liang J, Lauzon M, Luu M, Noureddin M, Ayoub W, Kuo A, Sankar K, Gong J, Hendifar A, Osipov A, Friedman ML, Lipshutz HG, Steinberger J, Kosari K, Nissen N, Abou-Alfa GK, Singal AG, Yang JD. Yeo YH, et al. Among authors: gong j. Am J Gastroenterol. 2023 Dec 1;118(12):2201-2211. doi: 10.14309/ajg.0000000000002467. Epub 2023 Aug 10. Am J Gastroenterol. 2023. PMID: 37561061
Regulation of antigen-specific T cell infiltration and spatial architecture in multiple myeloma and premalignancy.
Robinson MH, Villa NY, Jaye DL, Nooka AK, Duffy A, McCachren SS, Manalo J, Switchenko JM, Barnes S, Potdar S, Azeem MI, Horvat AA, Parihar VC, Gong J, Liang Y, Smith GH, Gupta VA, Boise LH, Kaufman JL, Hofmeister CC, Joseph NS, Lonial S, Dhodapkar KM, Dhodapkar MV. Robinson MH, et al. Among authors: gong j. J Clin Invest. 2023 Aug 1;133(15):e167629. doi: 10.1172/JCI167629. J Clin Invest. 2023. PMID: 37526080 Free PMC article.
7,588 results